Preview Mode Links will not work in preview mode

This Week in Cardiology

Jun 24, 2022

A non-significant but wonderful trial in AF, smoking and HF, vitamins, and pre-op risk screening are the topics discussed by John Mandrola, MD, in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:


DECAAF II: AF, Fibrosis Ablation Technique Falls Short, but Signs of Hope

Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation

Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation

II – Smoking and HF

Cigarettes Linked to HF With Preserved or Reduced EF

Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction

III – Vitamins

Evidence Still Lacking That Vitamins Prevent CVD, Cancer: USPSTF

Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement

IV – Pre-Op Risk

Add Atrial Fibrillation to Pre-Noncardiac Surgery Risk Evaluation: New Support

Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery

Patterns and Determinants of Low-Value Preoperative Testing in Michigan

Coronary-Artery Revascularization before Elective Major Vascular Surgery

Stress testing before abdominal aortic aneurysm repair does not lead to a reduction in perioperative cardiac events

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact